Astec Lifesciences (NSE:ASTEC) 3-Year EBITDA Growth Rate: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ASTEC Astec Lifesciences Ltd NSE:ASTEC
74 GF Score
Price ₹601.85
GF Value ₹902.14
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Astec Lifesciences 3-Year EBITDA Growth Rate?

Astec Lifesciences NSE:ASTEC +0.01% 74 3-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates NSE:ASTEC with a GF Score™ of 74/100 and a GF Value™ of ₹902.14 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 229 Agriculture companies, Astec Lifesciences ranks worse than 436680.79% on this metric.

Astec Lifesciences's EBITDA per Share for the three months ended in Jun. 2026 was ₹0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Astec Lifesciences was 34.90% per year. The lowest was -26.40% per year. And the median was 14.60% per year.

Astec Lifesciences  (NSE:ASTEC) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Astec Lifesciences 3-Year EBITDA Growth Rate Related Terms

NSE:ASTEC vs CTVA, CF, MOS: 3-Year EBITDA Growth Rate Comparison

For the Agricultural Inputs subindustry, Astec Lifesciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astec Lifesciences 3-Year EBITDA Growth Rate vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Astec Lifesciences's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Astec Lifesciences's 3-Year EBITDA Growth Rate falls into.


NSE:ASTEC
74GF Score
Astec Lifesciences Ltd NSE:ASTEC
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astec Lifesciences 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Astec Lifesciences (NSE:ASTEC) has a 3-Year EBITDA Growth Rate of 0.00% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Astec Lifesciences and its competitors. According to the industry distribution chart, Astec Lifesciences ranks #999999 out of 229 companies in the Agriculture industry.
Is Astec Lifesciences' 3-Year EBITDA Growth Rate too high?
Astec Lifesciences' current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, Astec Lifesciences ranks #999999 out of 229 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Astec Lifesciences has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' 3-Year EBITDA Growth Rate compare to CTVA and CF?
According to the Agriculture industry distribution chart, Astec Lifesciences ranks #999999 out of 229 companies for 3-Year EBITDA Growth Rate. This places Astec Lifesciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Agriculture company?
A good 3-Year EBITDA Growth Rate depends on the Agriculture industry context. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Astec Lifesciences and its competitors. Astec Lifesciences's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹902.14, compared to a current price of ₹601.85 — trading 33.3% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 0.00%. Astec Lifesciences' overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current 3-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued. The current stock price of ₹601.85 is trading 33.3% below its estimated GF Value™ of ₹902.14. GuruFocus considers Astec Lifesciences to be Significantly Undervalued.

Key valuation signals for NSE:ASTEC:

  • 3-Year EBITDA Growth Rate: 0.00%
  • GF Value™: ₹902.14 vs. price of ₹601.85 (33.3% below fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astec Lifesciences Business Description

Other Exchanges 533138:India
Address Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
74GF Score

Get the complete analysis for NSE:ASTEC

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹601.85
Price
₹902.14
GF Value